Natixis Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$241M Sell
540,530
-60,657
-10% -$27M 0.38% 46
2025
Q1
$291M Buy
601,187
+43,543
+8% +$21.1M 0.54% 28
2024
Q4
$225M Buy
557,644
+95,758
+21% +$38.6M 0.42% 43
2024
Q3
$215M Buy
461,886
+25,301
+6% +$11.8M 0.42% 44
2024
Q2
$205M Buy
436,585
+104,522
+31% +$49M 0.44% 38
2024
Q1
$139M Buy
332,063
+12,587
+4% +$5.26M 0.32% 67
2023
Q4
$130M Buy
319,476
+266
+0.1% +$108K 0.34% 63
2023
Q3
$111M Sell
319,210
-153,998
-33% -$53.6M 0.34% 63
2023
Q2
$167M Buy
473,208
+10,220
+2% +$3.6M 0.51% 32
2023
Q1
$146M Sell
462,988
-4,344
-0.9% -$1.37M 0.5% 35
2022
Q4
$135M Sell
467,332
-41,088
-8% -$11.9M 0.51% 33
2022
Q3
$147M Sell
508,420
-95,775
-16% -$27.7M 0.62% 19
2022
Q2
$170M Sell
604,195
-66,323
-10% -$18.7M 0.75% 13
2022
Q1
$175M Buy
670,518
+2,716
+0.4% +$709K 0.67% 18
2021
Q4
$147M Buy
667,802
+51,094
+8% +$11.2M 0.56% 30
2021
Q3
$112M Buy
616,708
+407,937
+195% +$74M 0.46% 43
2021
Q2
$42.1M Buy
208,771
+37,665
+22% +$7.59M 0.2% 125
2021
Q1
$36.8M Buy
171,106
+30,638
+22% +$6.58M 0.19% 135
2020
Q4
$33.2M Sell
140,468
-69,574
-33% -$16.4M 0.19% 129
2020
Q3
$57.2M Buy
210,042
+13,085
+7% +$3.56M 0.36% 55
2020
Q2
$57.2M Buy
196,957
+40,730
+26% +$11.8M 0.38% 51
2020
Q1
$37.2M Buy
156,227
+16,901
+12% +$4.02M 0.3% 71
2019
Q4
$30.5M Buy
139,326
+1,060
+0.8% +$232K 0.22% 100
2019
Q3
$23.4M Buy
138,266
+8,660
+7% +$1.47M 0.19% 131
2019
Q2
$23.8M Buy
129,606
+8,585
+7% +$1.57M 0.19% 119
2019
Q1
$22.3M Sell
121,021
-8,150
-6% -$1.5M 0.19% 116
2018
Q4
$21.4M Buy
129,171
+2,881
+2% +$477K 0.21% 100
2018
Q3
$24.3M Buy
126,290
+10,203
+9% +$1.97M 0.21% 95
2018
Q2
$19.7M Buy
116,087
+36,853
+47% +$6.26M 0.19% 115
2018
Q1
$12.9M Sell
79,234
-21
-0% -$3.42K 0.13% 175
2017
Q4
$11.9M Sell
79,255
-2,882
-4% -$432K 0.12% 203
2017
Q3
$12.5M Sell
82,137
-3,388
-4% -$515K 0.13% 177
2017
Q2
$11M Sell
85,525
-8,551
-9% -$1.1M 0.12% 201
2017
Q1
$10.3M Buy
94,076
+931
+1% +$102K 0.11% 212
2016
Q4
$6.86M Buy
93,145
+23,247
+33% +$1.71M 0.08% 304
2016
Q3
$6.1M Buy
69,898
+6,663
+11% +$581K 0.08% 319
2016
Q2
$5.44M Sell
63,235
-1,620
-2% -$139K 0.08% 339
2016
Q1
$5.16M Buy
64,855
+14,372
+28% +$1.14M 0.08% 327
2015
Q4
$6.35M Buy
50,483
+1,814
+4% +$228K 0.1% 245
2015
Q3
$5.07M Buy
48,669
+4,234
+10% +$441K 0.09% 312
2015
Q2
$5.49M Buy
44,435
+503
+1% +$62.1K 0.09% 304
2015
Q1
$5.18M Buy
43,932
+820
+2% +$96.7K 0.09% 331
2014
Q4
$5.12M Sell
43,112
-837
-2% -$99.4K 0.1% 322
2014
Q3
$4.94M Buy
43,949
+4,188
+11% +$470K 0.1% 320
2014
Q2
$3.77M Buy
39,761
+1,543
+4% +$146K 0.05% 521
2014
Q1
$2.7M Buy
38,218
+3,517
+10% +$249K 0.04% 565
2013
Q4
$2.58M Sell
34,701
-937
-3% -$69.6K 0.04% 556
2013
Q3
$2.7M Sell
35,638
-3,525
-9% -$267K 0.05% 511
2013
Q2
$3.14M Buy
+39,163
New +$3.14M 0.06% 468